There are two distinct phenotypes of multiple sclerosis (MS) in Asians, manifesting as optic-spinal (OSMS) and conventional (CMS) forms. In Japan, four nationwide surveys of MS have been conducted. The first three were in 1972, 1982, and 1989, and we performed the fourth in 2004.
Results
The recent survey showed six main findings as follows: (1) a four-fold increase in the estimated number of clinically definite patients with MS in 2003 (9900; crude MS prevalence, 7.7/100,000) compared with 1972; (2) a shift in the peak age at onset from early 30s in 1989 to early 20s in 2003; (3) a successive proportional decrease in optic-spinal involvement in clinically definite patients with MS; (4) a significant north–south gradient for the CMS/OSMS ratio; (5) after subdivision of the mainland (30–45° North) into northern and southern parts at 37°N, northern-born northern residents (northern patients) showed a significantly higher CMS/OSMS ratio and higher frequency of brain lesions fulfilling the Barkhof criteria (Barkhof brain lesions) than southern-born southern residents (southern patients); (6) among northern patients, the absolute numbers of patients with CMS and those with Barkhof brain lesions rapidly increased with advancing birth year.
Conclusions
These findings suggest that MS phenotypes are drastically altered by environmental factors, such as latitude and “Westernization.”
1 Compston A Coles A . Multiple sclerosis. Lancet2002; 359: 1221–1231.
2.
2 Kira J . Multiple sclerosis in the Japanese population. Lancet Neurol2003; 2: 117–127.
3.
3 Okinaka S Tsubaki T Kuroiwa Y Toyokura Y Imamura Y Yoshikawa M . Multiple sclerosis and allied diseases in Japan. Clinical characteristics. Neurology1958; 8: 756–763.
4.
4 Shibasaki H Kuroiwa Y . Clinical studies of multiple sclerosis in Japan. II. Are its clinical characteristics changing? Neurology1973; 23: 618–622.
5.
5 Kira J Kanai T Nishimura Y . Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol1996; 40: 569–574.
6.
6 Lennon VA Wingerchuk DM Kryzer TJ . A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet2004; 364: 2106–2112.
7.
7 Nakashima I Fujihara K Miyazawa I . Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry2006; 77: 1073–1075.
8.
8 Matsuoka T Matsushita T Kawano Y . Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain2007; 130: 1206–1223.
9.
9 Weinshenker BG Wingerchuk DM Nakashima I Fujihara K Lennon VA . OSMS is NMO, but not MS: proven clinically and pathologically. Lancet Neurol2006; 5: 110–111.
10.
10 Kikuchi S Fukazawa T . “OSMS is NMO, but not MS”: confirmed by NMO-IgG? Lancet Neurol2005; 4: 594–595.
11.
11 Compston A . Complexity and heterogeneity of demyelinating disease. Brain2007; 130: 1178–1180.
12.
12 Osuntokun BO . The pattern of neurological illness in tropical Africa. Experience at Ibadan, Nigeria. J Neurol Sci1971; 12: 417–442.
13.
13 Cree BA Khan O Bourdette D . Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology2004; 63: 2039–2045.
14.
14 Compston A . Genetic epidemiology of multiple sclerosis. J Neurol Neurosurg Psychiatry1997; 62: 553–561.
15.
15 Kurtzke JF Kurland LT Goldberg ID . Mortality and migration in multiple sclerosis. Neurology1971; 21: 1186–1197.
16.
16 Detels R Visscher BR Haile RW Malmgren RM Dudley JP Coulson AH . Multiple sclerosis and age at migration. Am J Epidemiol1978; 108: 386–393.
17.
17 Elian M Nightingale S Dean G . Multiple sclerosis among United Kingdom-born children of immigrants from the Indian subcontinent, Africa and the West Indies. J Neurol Neurosurg Psychiatry1990; 53: 906–911.
18.
18 Dean G Elian M . Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis. J Neurol Neurosurg Psychiatry1997; 63: 565–568.
19.
19 Hammond SR English DR McLeod JG . The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia. Brain2000; 123: 968–974.
20.
20 Sánchez JL Palacio LG Uribe CS . Clinical features of multiple sclerosis in a genetically homogeneous tropical population. Mult Scler2001; 7: 227–229.
21.
21 Cabre P Signate A Olindo S . Role of return migration in the emergence of multiple sclerosis in the French West Indies. Brain2005; 128: 2899–2910.
22.
22 Alvarado-de la Barrera C Zúňiga-Ramos J Ruīiz-Morales JA Estaňol B Granados J Llorente L . HLA class II genotypes in Mexican Mestizos with familial and nonfamilial multiple sclerosis. Neurology2000; 55: 1897–1900.
23.
23 Kuroiwa Y Igata A Itahara K Koshijima S Tsubaki T . Nationwide survey of multiple sclerosis in Japan. Clinical analysis of 1,084 cases. Neurology1975; 25: 845–851.
24.
24 Shibasaki H Kubo N Nishitani H Saida T Ohno Y Fukuyama Y . Nationwide survey of multiple sclerosis in Japan: reappraisal of clinical features. J Trop Geo Neurol1992; 2: 73–82.
25.
25 Miura K Nakagawa H Morikawa Y . Epidemiology of idiopathic cardiomyopathy in Japan: results from a nationwide survey. Heart2002; 87: 126–130.
26.
26 Schumacher GA Beebe GW Kibler RF . Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci1965; 122: 552–568.
27.
27 McDonald WI Compston A Edan G . Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol2001; 50: 121–127.
28.
28 Yamasaki K Horiuchi I Minohara M . HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies. Brain1999; 122: 1689–1696.
29.
29 Hashimoto S Fukutomi K Nagai M . Response bias in the nationwide epidemiological survey of an intractable disease in Japan. J Epidemiol1991; 1: 27–30.
30.
30 Hashimoto S Fukutomi K Nagai M . A method of interval estimation for number of patients in the nationwide epidemiological survey on intractable diseases. Jpn J Public Health1991; 38: 880–883 [in Japanese].
31.
31 Kurtzke JF . Rating neurologic impaiment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology1983; 33: 1444–1452.
32.
32 Barkhof F Filippi M Miller DH . Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain1997; 120: 2059–2069.
33.
33 Saida T Tashiro K Itoyama Y Sato T Ohashi Y Zhao Z . Interferon beta-1b is effective in Japanese RRMS patients: a randomized, multicenter study. Neurology2005; 64: 621–630.
34.
34 Houzen H Niino M Kikuchi S . The prevalence and clinical characteristics of MS in northern Japan. J Neurol Sci2003; 211: 49–53.
35.
35 Itoh T Aizawa H Hashimoto K . Prevalence of multiple sclerosis in Asahikawa, a city in northern Japan. J Neurol Sci2003; 214: 7–9.
36.
36 Noonan CW Kathman SJ White MC . Prevalence estimates for MS in the United States and evidence of an increasing trend for women. Neurology2002; 58: 136–138.
37.
37 Barnett MH Williams DB Day S Macaskill P McLeod JG . Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 35-year study. J Neurol Sci2003; 213: 1–6.
38.
38 Wallin MT Page WF Kurtzke JF . Multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex, and geography. Ann Neurol2004; 55: 65–71.
39.
39 Orton S-M Herrera B Yee IM Valdar W Ramagopalan SV Sadovnic AD . ; for the Canadian Collaborative Study Group.Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol2006; 5: 932–936.
40.
40 Cocco E Sardu C Lai M Spinicci G Contu P Marrosu MG . Anticipation of age at onset in multiple sclerosis: a Sardinian cohort study. Neurology2004; 62: 1794–1798.
41.
41 Marrosu MG Cocco E Lai M Spinicci G Pischedda MP Contu P . Patietns with multiple sclerosis and risk of type 1 diabetes mellitus in Sardinia, Italy: a cohort study. Lancet2002; 359: 1461–1465.
42.
42 Kennedy J O'Connor P Sadovnick AD Perara M Yee I Banwell B . Age at onset of multiple sclerosis may be influenced by place of residence during childhood rather than ancestry. Neuroepidemiology2006; 26: 162–167.
43.
43 Tanaka K Tani T Tanaka M . Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions. Mult Scler2007; 13: 850–855.
44.
44 Kira J Yamasaki K Horiuchi I Ohyagi Y Taniwaki T Kawano Y . Changes in the clinical phenotypes of multiple sclerosis during the past 50 years in Japan. J Neurol Sci1999; 166: 53–57.
45.
45 Nakashima I Fujihara K Takase S Itoyama Y . Decrease in multiple sclerosis with acute transverse myelitis in Japan. Tohoku J Exp Med1999; 188: 89–94.
46.
46 Wingerchuk DM Hogancamp WF O'Brien PC Weinshenker BG . The clinical course of neuromyelitis optica (Devic's syndrome). Neurology1999; 53: 1107–1114.
47.
47 Tartaglino LM Friedman DP Flanders AE Lublin FD Knobler RL Liem M . Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. Radiology1995; 195: 725–732.
48.
48 Su J-J Osoegawa M Minohara M . Upregulation of vascular growth factors in multiple sclerosis: correlation with MRI findings. J Neurol Sci2006; 243: 21–30.
49.
49 Minohara M Matsuoka T Li W . Upregulation of myeloperoxidase in patients with opticospinal multiple sclerosis: positive correlation with disease severity. J Neuroimmunol2006; 178: 156–160.
50.
50 Bot JC Barkhof F Polman CH . Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination. Neurology2004; 62: 226–233.
51.
51 Department of Environmental Health, Hokkaido Prefecture Government.. The 2006 Hokkaido Ainu Current Living Conditions Survey Report. 2006 [In Japanese].
52.
52 Bannai M Ohashi J Harihara S . Analysis of HLA genes and haplotypes in Ainu (from Hokkaido, northern Japan) supports the premise that they descent from Upper Paleolithic populations of East Asia. Tissue Antigens2000; 55: 128–139.
53.
53 Tajima A Hayami M Tokunaga K . Genetic origins of the Ainu inferred from combined DNA analyses of maternal and paternal lineages. J Hum Genet2004; 49: 187–193.
